Impact Biomedical Inc. Files 8-K for Material Agreement
Ticker: IBO · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1834105
| Field | Detail |
|---|---|
| Company | Impact Biomedical Inc. (IBO) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-K, regulatory-filing
TL;DR
Impact Biomedical Inc. signed a material definitive agreement on June 21, 2025. 8-K filed June 23.
AI Summary
Impact Biomedical Inc. filed an 8-K on June 23, 2025, reporting a material definitive agreement entered into on June 21, 2025. The filing also includes Regulation FD disclosures and financial statements/exhibits. The company is incorporated in Nevada and its principal executive offices are located in Houston, Texas.
Why It Matters
This 8-K filing indicates a significant event for Impact Biomedical Inc., potentially involving a new contract, partnership, or acquisition that could impact its business operations and financial performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could represent significant opportunities or risks depending on the nature of the agreement.
Key Players & Entities
- Impact Biomedical Inc. (company) — Registrant
- June 23, 2025 (date) — Filing Date
- June 21, 2025 (date) — Date of Earliest Event Reported
- Nevada (jurisdiction) — State of Incorporation
- Houston, TX (location) — Address of Principal Executive Offices
- 001-42212 (identifier) — SEC File Number
FAQ
What is the nature of the material definitive agreement entered into by Impact Biomedical Inc. on June 21, 2025?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on June 21, 2025.
When did Impact Biomedical Inc. file this 8-K report?
Impact Biomedical Inc. filed this 8-K report on June 23, 2025.
What is the state of incorporation for Impact Biomedical Inc.?
Impact Biomedical Inc. is incorporated in Nevada.
Where are the principal executive offices of Impact Biomedical Inc. located?
The principal executive offices of Impact Biomedical Inc. are located at 1400 Broadfield Blvd., Suite 130, Houston, TX 77084.
What is the SEC file number for Impact Biomedical Inc.?
The SEC file number for Impact Biomedical Inc. is 001-42212.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding IMPACT BIOMEDICAL INC. (IBO).